Regulatory

Latest News

test tubes with colored liquid | Image credit: fotofabrika - stock.adobe.com
BioRationality: MHRA's Procedure Enables Automatic Registration of Biosimilars Approved Elsewhere

March 18th 2024

Sarfaraz K. Niazi, PhD, explains how the new international regognition procedure under the Medicines and Healthcare products Regulatory Agency (MHRA) could expand biosimilar access within the United kingdom, in his latest column.

globe health care | Image credit: Planetz - stock.adobe.com
Adalimumab Expenditures in Countries With and Without Available Biosimilars

March 16th 2024

FDA images | Image credit: wlandimir1804 - stock.adobe.com
FDA Green Lights Second Tocilizumab Biosimilar

March 7th 2024

Guy holding paper "FDA Approved" | Image credit: gustavofrazao - stock.adobe.com
FDA Approves First Denosumab Biosimilars

March 5th 2024

researcher and data | Image credit: Deemerwha studio - stock.adobe.com
BioRationality: EMA Announces Readiness to Waive Comparative Efficacy Studies of Biosimilars

March 4th 2024

Video Interviews
Podcasts
CFB podcast banner
CFB podcast banner
CfB Podcast Banner
"SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars" with the CfB logo and an image of an eye
CfB podcast banner
CfB podcast banner
podcast banner
image of adalimumab biosmilar eveloped by alvotech prefilled syring
canadian flag on a mountain
CfB podcast banner

More News

© 2024 MJH Life Sciences

All rights reserved.